EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieOpen Access · CC BY 4.0

PRAP study—partial versus radical adrenalectomy in hereditary pheochromocytomas

Kai Xu iD, Johan F Langenhuijsen, Charlotte L Viëtor, Richard A Feelders, Tessa M van Ginhoven, Yasir S Elhassan iD, Fabio Bioletto iD, Mirko Parasiliti-Caprino iD, Wouter T Zandee iD, Schelto Kruijff, Samuel Backman, Tobias Åkerström und 11 weitere

European Journal of Endocrinology · 2024

DOI: 10.1093/ejendo/lvae108 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Kai Xu und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Pheochromocytoma, Adrenalectomy, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Hereditary pheochromocytoma (hPCC) commonly develops bilaterally, causing adrenal insufficiency when standard treatment, radical adrenalectomy (RA), is performed. Partial adrenalectomy (PA) aims to preserve adrenal function, but with higher recurrence rates. This study compares outcomes of PA versus RA in hPCC.

Methods

Patients with hPCC due to pathogenic variants in RET, VHL, NF1, MAX, and TMEM127 from 12 European centers (1974–2023) were studied retrospectively. Stratified analysis based on surgery type and initial presentation was conducted. The main outcomes included recurrence, adrenal insufficiency, metastasis, and mortality.

Results

The study included 256 patients (223 RA, 33 PA). Ipsilateral recurrence rates were 9/223 (4%) after RA versus 5/33 (15%) after PA (P = 0.02). Metastasis and mortality did not differ between groups. Overall, 103 patients (40%) underwent bilateral adrenalectomy either synchronously or metachronously (75 RA, 28 PA). Of these, 46% developed adrenal insufficiency after PA. In total, 191 patients presented with initial unilateral disease, of whom 50 (26%) developed metachronous contralateral disease, most commonly in RET, VHL, and MAX. In patients with metachronous bilateral disease, adrenal insufficiency developed in 3/4 (75%) when PA was performed as the first operation followed by RA, compared to 1/7 (14%) when PA was performed as the second operation after prior RA (P = 0.09).

Conclusion

In patients with hPCC undergoing PA, local recurrence rates are higher than after RA, but metastasis and disease-specific mortality are similar. Therefore, PA seems a safe method to preserve adrenal function in patients with hPCC, in cases of both synchronous and metachronous bilateral disease, when performed as a second operation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PheochromocytomaAdrenalectomyAdrenal Gland NeoplasmsHumansFemaleMaleAdultRetrospective StudiesMiddle AgedYoung AdultAdolescentNeoplasm Recurrence, LocalAdrenal InsufficiencyTreatment OutcomeAgedChild

Stichwörter der Autor:innen

adrenalectomycortical-sparinggeneticspheochromocytomatotal

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
  • Department of Urology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
  • Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, 3008 AE Rotterdam, The Netherlands.
  • Department of Internal Medicine, Division of Endocrinology, Erasmus MC, 3015 GD Rotterdam, The Netherlands.
  • University of Birmingham, Institute of Metabolism and Systems Research, B15 2TT Birmingham, United Kingdom.
  • Birmingham Health Partners, Centre for Endocrinology, Diabetes and Metabolism, B15 2TT Birmingham, United Kingdom.

ORCID-Profile: Kai Xu, Yasir S Elhassan, Fabio Bioletto, Mirko Parasiliti-Caprino, Wouter T Zandee, Nicole Bechmann, Charlotte Lussey-Lepoutre, Letizia Canu, Koen M A Dreijerink, Joanne M de Laat

Zitieren

APA

Xu, K., Langenhuijsen, J. F., Viëtor, C. L., Feelders, R. A., van Ginhoven, T. M., Elhassan, Y. S., Bioletto, F., Parasiliti-Caprino, M., Zandee, W. T., Kruijff, S., Backman, S., Åkerström, T., Pamporaki, C., Bechmann, N., Lussey-Lepoutre, C., Canu, L., Steenaard, R. V., Driessens, N., Velema, M., …, & de Laat, J. M. (2024). PRAP study—partial versus radical adrenalectomy in hereditary pheochromocytomas. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae108

Vancouver

Xu K, Langenhuijsen JF, Viëtor CL, Feelders RA, van Ginhoven TM, Elhassan YS, et al. PRAP study—partial versus radical adrenalectomy in hereditary pheochromocytomas. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae108

BibTeX
@article{Xu2024,
  author = {Xu, Kai and Langenhuijsen, Johan F and Viëtor, Charlotte L and Feelders, Richard A and van Ginhoven, Tessa M and Elhassan, Yasir S and Bioletto, Fabio and Parasiliti-Caprino, Mirko and Zandee, Wouter T and Kruijff, Schelto and Backman, Samuel and Åkerström, Tobias and Pamporaki, Christina and Bechmann, Nicole and Lussey-Lepoutre, Charlotte and Canu, Letizia and Steenaard, Rebecca V and Driessens, Natacha and Velema, Marieke and Dreijerink, Koen M A and Engelsman, Anton F and Timmers, Henri J L M and de Laat, Joanne M},
  title = {PRAP study—partial versus radical adrenalectomy in hereditary pheochromocytomas},
  journal = {European Journal of Endocrinology},
  year = {2024},
  doi = {10.1093/ejendo/lvae108}
}
Kostenlos starten →